Recent advances in study of sphingolipids on liver diseases.
- Author:
Shaoyuan WANG
;
Jinlan ZHANG
;
Dan ZHANG
;
Xiuqi BAO
;
Hua SUN
- Publication Type:Journal Article
- From:
Acta Pharmaceutica Sinica
2015;50(12):1551-8
- CountryChina
- Language:Chinese
-
Abstract:
Sphingolipids, especially ceramide and S1P, are structural components of biological membranes and bioactive molecules which participate in diverse cellular activities such as cell division, differentiation, gene expression and apoptosis. Emerging evidence demonstrates the role of sphingolipids in hepatocellular death, which contributes to the progression of several liver diseases including ischaemia-reperfusion liver injury, steatohepatitis or hepatocarcinogenesis. Furthermore, some data indicate that the accumulation of some sphingolipids contributes to the hepatic dysfunctions. Hence, understanding of sphingolipid may open up a novel therapeutic avenue to liver diseases. This review focuses on the progress in the sphingolipid metabolic pathway with a focus on hepatic diseases and drugs targeting the sphingolipid pathway.
